Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Taylor

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
ACS Medicinal Chemistry Letters|November 17, 2023
Design of Novel Series of Antimalarial PMX Inhibitors with Increased Half-Life via Molecular Property OptimizationKomei Sakata, Martin A Lowe, Mengyang Xuan, et al.
Journal of Medicinal Chemistry|May 29, 2009
Novel potent BRAF inhibitors: toward 1 nM compounds through optimization of the central phenyl ringDelphine Ménard, Ion Niculescu-Duvaz, Harmen P Dijkstra, et al.
Scientific Reports|January 31, 2017
Discovery of a junctional epitope antibody that stabilizes IL-6 and gp80 protein:protein interaction and modulates its downstream signalingRalph Adams, Rebecca J Burnley, Chiara R Valenzano, et al.
Journal of Medicinal Chemistry|March 28, 2009
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF)Dan Niculescu-Duvaz, Catherine Gaulon, Harmen P Dijkstra, et al.
ACS Chemical Biology|August 18, 2021
The Chemical Synthesis of Knob Domain Antibody FragmentsAlex Macpherson, James R Birtley, Robert J Broadbridge, et al.
Plos Biology|May 22, 2018
Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMRDaniel Stöppler, Alex Macpherson, Susanne Smith-Penzel, et al.
Journal of Medicinal Chemistry|October 10, 2022
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of <b>UCB7362</b>Martin A Lowe, Alvaro Cardenas, Jean-Pierre Valentin, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
ACS Medicinal Chemistry Letters|November 17, 2023
Design of Novel Series of Antimalarial PMX Inhibitors with Increased Half-Life via Molecular Property OptimizationKomei Sakata, Martin A Lowe, Mengyang Xuan, et al.
Journal of Medicinal Chemistry|May 29, 2009
Novel potent BRAF inhibitors: toward 1 nM compounds through optimization of the central phenyl ringDelphine Ménard, Ion Niculescu-Duvaz, Harmen P Dijkstra, et al.
Scientific Reports|January 31, 2017
Discovery of a junctional epitope antibody that stabilizes IL-6 and gp80 protein:protein interaction and modulates its downstream signalingRalph Adams, Rebecca J Burnley, Chiara R Valenzano, et al.
Journal of Medicinal Chemistry|March 28, 2009
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF)Dan Niculescu-Duvaz, Catherine Gaulon, Harmen P Dijkstra, et al.
ACS Chemical Biology|August 18, 2021
The Chemical Synthesis of Knob Domain Antibody FragmentsAlex Macpherson, James R Birtley, Robert J Broadbridge, et al.
Plos Biology|May 22, 2018
Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMRDaniel Stöppler, Alex Macpherson, Susanne Smith-Penzel, et al.
Journal of Medicinal Chemistry|October 10, 2022
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of <b>UCB7362</b>Martin A Lowe, Alvaro Cardenas, Jean-Pierre Valentin, et al.
Pageof 3